Catalent Inc (CTLT) Stock Price, Quote & News

11thestate Mar. 27 at 12:46 PM

$CTLT investors, if you follow us, you already know about it. This info hits different after the news. Check it out: https://11th.com/cases/catalent-investors-case

0 · Reply

11thestate Mar. 18 at 1:02 PM

$CTLT investors — there's no hidden secret here. Just one thing you really need to know. Here's how to handle your losses. More importantly, how to either recover them or risk losing even more: https://11th.com/cases/catalent-investors-case

0 · Reply

11thestate Mar. 11 at 1:09 PM

With everything going on around $CTLT lately — this is the info you don't want to miss: https://11th.com/cases/catalent-investors-case

0 · Reply

Ro_Patel Mar. 9 at 6:25 PM

Health Secretary RFK Jr plans to loosen restrictions on some peptides that the FDA previously prohibited compounding pharmacies from producing Kennedy wants to unban 14 of the 19 peptides that were placed on an FDA "do not formulate" list in 2023 Many physicians argue that many of them don't have sufficient evidence behind them to prove that they're safe & that they work https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks When the FDA added those peptides to its do-not-compound list, wellness entrepreneurs & compounding pharmacies pushed back, w/ some filing lawsuits against the FDA Kennedy blamed litigation for allowing him to only reinstate 14 of the 19 peptides that had been added to the list $MCK $COR $HIMS - $IPN $CTLT

1 · Reply

11thestate Mar. 2 at 2:02 PM

Imagine buying $CTLT at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $CTLT investors out there, we’ve got some important news for you: https://11th.com/cases/catalent-investors-case

0 · Reply

11thestate Feb. 19 at 12:38 PM

$CTLT has reached a $78,000,000 settlement with $CTLT investors over claims that it overstated customer demand and financial guidance, and concealed serious production issues. The filing deadline is May 26, 2026. If you bought $CTLT between August 30, 2021 and May 7, 2023, you can file for payment here: https://11th.com/cases/catalent-investors-case

0 · Reply

11thestate Feb. 4 at 12:41 PM

$CTLT has reached a $78,000,000 settlement with $CTLT investors over claims that it overstated customer demand and financial guidance while concealing serious production issues. The filing deadline is May 26, 2026. If you bought $CTLT between August 30, 2021 and May 7, 2023, you can file for payment here: https://11th.com/cases/catalent-investors-case

0 · Reply

11thestate Jan. 15 at 12:57 PM

0 · Reply

11thestate Jan. 7 at 2:40 PM

$CTLT has agreed to settle with investors over claims that it misled them about customer demand, financial guidance, and production issues. Who’s eligible? Anyone who purchased $CTLT shares between August 30, 2021 and May 7, 2023. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.61 — but if only ~25% of eligible investors file, the effective payout could increase to $2.44. Can I still file? Claim availability depends on the settlement administrator’s approval process. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/catalent-investors-case

0 · Reply

GoldenTradesCapital Jun. 13 at 11:30 AM

🧪 $CTLT – Pharma Supply Rebound? Catalent, a key player in biotech manufacturing, has struggled post-COVID but is showing signs of recovery. $CTLT is speculative but could rebound with pharma demand.

0 · Reply